Active

Lauxera Capital Partners

Investor type

VC

Founded

2020

AUM

$1 000 M

Location

Paris, Île-de-France, France

Investment Ticket

$10-50 m

Investment Stage

Series A Series B Late Stage (Series C+)

Region of investment

North America Europe Asia

ESG Focus

Impact investor
Investor profile last updated: 21 August, 2026

Profile

Lauxera Capital Partners is a Healthtech growth investor with offices in Paris and San Francisco. The firm was founded by Victor Decrion, who serves as Managing Partner, together with co-founders Pierre Moustial, Samuel Levy, and Alex Slack. The team is 16 people across investing, operations, investor relations, and ESG. Lauxera works only with founders who have already built a profitable business and need help scaling - going global, hiring senior operators, and bolt-on M&A.

The firm invests only in Healthtech. That means medical devices, pharma services, digital health, healthcare software and data, and life science tools. Tickets are $10-50M at Series A through late-stage. Mandate is global - North America, Europe, and Asia. Total AUM is over $1B. Lauxera Growth II is the latest fund, closed at $572M in May 2026, above target. Fund I launched in 2021. Lauxera also funds rare-disease research through a charity partnership with Institut Imagine.

Notable investments: OrganOx - organ preservation. Antaros Medical - drug imaging. Verdot - bioprocessing. Acandis - devices for stroke and aneurysms. Biolamina - cell culture matrices. Caresyntax - surgical data.

Industry

Healthcare Services Digital Medical Devices Pharmaceuticals Software MedTech Life Sciences HealthTech

Lauxera Capital Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Lauxera Growth II
Venture Capital (VC)
Digital
Healthcare Services
Medical Devices
Pharmaceuticals
Software
MedTech
Life Sciences
HealthTech
Late Stage (Series C+)
North America
Europe
Asia
$10-50 m
$572 M
May 2026
Lauxera Growth I Fund
Private Equity (PE)
Healthcare Services
Software
HealthTech
Series B
Late Stage (Series C+)
North America
Europe
$5-10 m
$260 M
February 2022

Contacts

Name
Title
Email
avatar
Pierre Moustial Founding President
Founding President
p•••@•••
avatar
Samuel Levy Founding Partner
Founding Partner
s•••@•••
Upgrade to see contacts
avatar
fLSbrhPIjkzFGVgi fLSbrhPIjkzFGVgi
fLSbrhPIjkzFGVgi
avatar
fLSbrhPIjkzFGVgi fLSbrhPIjkzFGVgi
fLSbrhPIjkzFGVgi
avatar
fLSbrhPIjkzFGVgi fLSbrhPIjkzFGVgi
fLSbrhPIjkzFGVgi
Investment-team contacts for Lauxera Capital Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Lauxera Capital Partners

Lauxera Capital Partners is a venture capital firm. It backs companies at Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Lauxera Capital Partners is located in Paris, Île-de-France, France.
Lauxera Capital Partners was founded in 2020.
Lauxera Capital Partners invests in companies and startups in Healthcare Services, Digital, Medical Devices, Pharmaceuticals, Software, MedTech, Life Sciences, HealthTech.
Lauxera Capital Partners invests in companies and startups in North America, Europe, Asia.
Lauxera Capital Partners invests in companies and startups at Series A, Series B, Late Stage (Series C+).
Lauxera Capital Partners usually invests $10-50 m on average.
Lauxera Capital Partners has around $1 000m assets under management.
Lauxera Capital Partners last fund was created/launched in 2026-05-20
Yes, Lauxera Capital Partners is impact investor.
Lauxera Capital Partners can be reached through its website lauxera.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Lauxera Capital Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Lauxera Capital Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.